A. Karim Kader, MD, PhD
Stratify Genomics
CO-FOUNDER / BOARD MEMBER / CHIEF MEDICAL OFFICER
Dr A Karim Kader MD is the key note speaker at SAJAC – South African Jewish American Community –Â Genetics Symposium to be held virtually via ZOOM on October 15th, 2020 @ 4.00 PM PST
A. Karim Kader, MD, PhD, is a board-certified urologist who specializes in detecting, treating and preventing prostate cancer.
As a Professor in the Department of Urology and Director of Urologic Oncology at the University of California, San Diego, Dr. Kader instructs medical students, residents and fellows at UC San Diego School of Medicine. His current research interests include genetic markers of risk and outcome in urologic cancer.
In addition, he is examining the impact of augmented reality and enhanced imaging techniques for education and improved surgical outcomes. Dr. Kader completed a fellowship in urological oncology at the University of Texas MD Anderson Cancer Center in Houston and a residency in urology at the University of Toronto in Ontario, Canada.
He earned his medical degree and doctoral degree from the University of British Columbia in Vancouver, British Columbia. Dr. Kader is board certified in urology.
Dr. Kader is nationally recognized for his expertise in performing robot-assisted radical cystectomy and urinary diversion for patients with bladder cancer.
He holds several patents for genetic discoveries that are focused on the early detection and prevention of prostate cancer in addition to device patents for prostate cancer treatment. He is the principal investigator in numerous clinical research projects and has published extensively.
Why is this Symposium So Important?
